⚠️ FOR RESEARCH PURPOSES ONLY — This compound is not FDA approved. All data presented is from clinical trials for educational reference.

SELANK

A 7-amino acid synthetic heptapeptide derived from tuftsin that modulates GABAergic neurotransmission and BDNF expression, studied for anxiolytic and nootropic effects in clinical research. Premium Research Peptide.

$40.99

BUNDLE & SAVE

1 BOTTLE
2 BOTTLES
5% OFF
BEST VALUE
3+ BOTTLES
7.5% OFF

*Discount will be automatically applied in cart

🚚 Estimated delivery: Loading...
🛡️ Free shipping protection on every order
⚡ Same-day dispatch on orders before 2 PM EST
Accepted payment methods: Apple Pay, Visa, Discover, American Express

Ships from the USA

Same or next business day

Damage protection

every order covered

Secure checkout

256-bit SSL

Product specification

Compound data

Molecular Profile

Type
Synthetic heptapeptide
CAS Number
129954-34-3
Molecular Weight
751.9 g/mol
Amino Acids
7 residues
Formula
C33H57N11O9
Sequence
Thr-Lys-Pro-Arg-Pro-Gly-Pro
HeptapeptideTuftsin Analog

Storage Requirements

Light sensitiveTemperature sensitive

Development Status

Developer
Russian Academy of Sciences
Collaborator
V.V. Zakusov Institute
Approval
Russia (2009), Ukraine
Indication
Generalized Anxiety Disorder
US Status
Not FDA-approved
Formulation
0.15% nasal drops (Rx in Russia)
Lyophilized (powder) -20°C
protect from light
Reconstituted
2-8°C
Nasal spray 2-8°C
30 days after opening
⚠️ IMPORTANT RESEARCH NOTICE

Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.

All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.

By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.